Nyxoah announces US Commercial Patients Implanted with Genio System
October 6, 2025
Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorisations, and Widespread Payor Coverage
Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorisations, and Widespread Payor Coverage
Olympus announced today that it has launched its SecureFlex single-use fine needle biopsy device in Europe and Japan.
Medical Microinstruments Inc. (MMI) says its robotics system has been used for the first microsurgical intracranial brain surgeries.
Neurons in the brain communicate with each other through synapses—connection points that allow the passage of electrical and chemical signals. In non-neuronal cells, direct cell-to-cell connections have been found to occur with the assistance of nanotube structures
Grace will deliver conventional X-ray radiation therapy with patients positioned upright
Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease progression and survival in patients with fibrotic interstitial lung disease.
GlucoSet announced today on social media that it received FDA breakthrough device designation for its glucose monitoring technology.
NEWPORT BEACH, Calif., Oct. 3, 2025 /PRNewswire/ — Gnosis for Her, a mobile breast health initiative redefining comfort and access in women’s breast imaging, made its national debut this past weekend at Susan G. Komen’s More Than Pink Walk at Fashion Island. More than 6,000 breast cancer survivors, loved ones, advocates, and supporters had the opportunity to see the Mobile Care Unit up close, tour inside, and speak with the expert team behind the service.
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases (IBD), but also successfully used a new type of AI to predict exactly how the drug works. To their knowledge, this is a global first for the AI.
Trying to document how single brain cells participate in networks that govern behavior is a daunting task. Brain probes called Neuropixels, which feature high-density silicon arrays, have enabled scientists to collect electrophysiological data of this nature from a variety of animals